We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Revolutionizing In Vitro Disease Models With iPSC Reprogramming Technology

Scientists use human iPSC-derived cells to model human disease in the lab without relying on hard to source patient-derived cells or animal models that don't accurately recapitulate the complexity of human biology

In this Teach Me in 10, we are joined by Dr. Will Bernard to get a primer on the latest innovations in in vitro human cell technology, and learn how scientists are adopting these new tools to simplify and standardize experiments in human disease research, and drug discovery.

Further Information:

Brought to you by